iShares MSCI Europe IMI Index ETF (TSX: XEU)
Assets | 302.31M |
Expense Ratio | 0.29% |
PE Ratio | 14.39 |
Dividend (ttm) | 0.89 |
Dividend Yield | 2.96% |
Ex-Dividend Date | Jun 25, 2024 |
Payout Frequency | Semi-Annual |
Payout Ratio | 42.53% |
1-Year Return | +13.48% |
Volume | 2,164 |
Open | 30.08 |
Previous Close | 29.83 |
Day's Range | n/a |
52-Week Low | 25.00 |
52-Week High | 31.59 |
Beta | 0.98 |
Holdings | 1241 |
Inception Date | Apr 15, 2014 |
About XEU
The fund provides marketlike exposure to the developed Europe space. The fund tracks a broad MSCI index that invests in large- to small-cap companies, selected and weighted based on their market capitalization. The fund also uses a representative sampling strategy, which means it will invest in a sample of securities that collectively have an investment profile similar to that of the underlying index. In all, XEUs basket provides well-diversified, representative coverage of European stocks across the market cap spectrum. The index is rebalanced quarterly. Sibling fund XEH offers the same exposure but hedged to Canadian dollars.
Performance
XEU had a total return of 13.48% in the past year. Since the fund's inception, the average annual return has been 3.62%, including dividends.
Top 10 Holdings
22.25% of assetsName | Symbol | Weight |
---|---|---|
Novo Nordisk A/S Class B | NOVO B.CO | 3.89% |
ASML Holding NV | ASML.AS | 3.28% |
Nestle SA | NESN.SW | 2.27% |
Eur Cash | n/a | 2.25% |
AstraZeneca PLC | AZN.L | 1.99% |
Shell PLC | SHEL.L | 1.84% |
Lvmh Moet Hennessy Louis Vuitton SE | MC.PA | 1.76% |
Novartis AG Registered Shares | NOVN.SW | 1.71% |
SAP SE | SAP.DE | 1.64% |
Roche Holding AG | ROG.SW | 1.61% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Jun 25, 2024 | 0.633 CAD | Jun 28, 2024 |
Dec 28, 2023 | 0.25852 CAD | Jan 4, 2024 |
Jun 26, 2023 | 0.570 CAD | Jun 30, 2023 |
Dec 29, 2022 | 0.28197 CAD | Jan 5, 2023 |
Jun 24, 2022 | 0.463 CAD | Jun 30, 2022 |
Dec 30, 2021 | 0.28224 CAD | Jan 6, 2022 |